TC Biopharm (Holdings) Plc
TCBPY
$0.335
$0.026.35%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.52M | 1.63M | 1.27M | 1.24M | 3.14M |
| Total Receivables | 826.00K | 884.30K | 1.59M | 1.52M | 1.40M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 985.00K | 1.05M | 583.00K | 974.00K | 1.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.90M | 4.17M | 1.55M | 1.57M | 1.67M |
| Total Current Assets | 7.23M | 7.74M | 4.99M | 5.31M | 7.26M |
|
|
|||||
| Total Current Assets | 7.23M | 7.74M | 4.99M | 5.31M | 7.26M |
| Net Property, Plant & Equipment | 2.61M | 2.80M | 2.92M | 3.10M | 3.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 583.70K | 624.90K | 764.90K | 768.50K | 783.60K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 10.43M | 11.16M | 8.68M | 9.17M | 11.38M |
|
|
|||||
| Total Accounts Payable | 1.74M | 1.87M | 1.19M | 2.43M | 2.35M |
| Total Accrued Expenses | 2.74M | 2.93M | 2.64M | 2.77M | 3.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 411.20K | 440.20K | 397.80K | 389.20K | 388.90K |
| Total Finance Division Other Current Liabilities | 296.30K | 317.20K | 225.80K | 425.80K | 243.40K |
| Total Other Current Liabilities | 296.30K | 317.20K | 225.80K | 425.80K | 243.40K |
| Total Current Liabilities | 5.19M | 5.56M | 4.46M | 6.02M | 6.05M |
|
|
|||||
| Total Current Liabilities | 5.19M | 5.56M | 4.46M | 6.02M | 6.05M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.47M | 1.57M | 1.69M | 1.79M | 1.91M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.66M | 7.13M | 6.15M | 7.81M | 7.96M |
|
|
|||||
| Common Stock & APIC | 69.57M | 74.48M | 58.32M | 54.61M | 54.89M |
| Retained Earnings | -65.80M | -70.45M | -55.79M | -53.25M | -51.47M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.77M | 4.03M | 2.53M | 1.36M | 3.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.77M | 4.03M | 2.53M | 1.36M | 3.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.77M | 4.03M | 2.53M | 1.36M | 3.42M |
|
|
|||||